Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …
P Urban, R Mehran, R Colleran, DJ Angiolillo… - Circulation, 2019 - Am Heart Assoc
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …
coronary intervention are of major importance, but a lack of standardization in defining this …
The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease
East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during
antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor …
antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor …
JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease
M Nakamura, K Kimura, T Kimura, M Ishihara… - Circulation …, 2020 - jstage.jst.go.jp
In 2019, the Japanese Circulation Society published 2 guidelines in the field of coronary
artery disease (CAD):(1) a guideline for acute coronary syndrome (ACS) that integrated …
artery disease (CAD):(1) a guideline for acute coronary syndrome (ACS) that integrated …
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE …
Summary Background A potent P2Y12 inhibitor-based dual antiplatelet therapy is
recommended for up to 1 year in patients with acute coronary syndrome receiving …
recommended for up to 1 year in patients with acute coronary syndrome receiving …
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous …
Y Li, Z Liang, L Qin, M Wang, X Wang, H Zhang, Y Liu… - The Lancet, 2022 - thelancet.com
Background Previous randomised trials of bivalirudin versus heparin in patients with ST-
segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …
segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …
Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized …
DW Park, O Kwon, JS Jang, SC Yun, H Park, DY Kang… - Circulation, 2019 - Am Heart Assoc
Background: Owing to the differential propensity for bleeding and ischemic events with
response to antiplatelet therapy, the safety and effectiveness of potent P2Y12 inhibitor …
response to antiplatelet therapy, the safety and effectiveness of potent P2Y12 inhibitor …
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an …
DA Gorog, JL Ferreiro, I Ahrens, J Ako… - Nature Reviews …, 2023 - nature.com
Conventional dual antiplatelet therapy (DAPT) for patients with acute coronary syndromes
undergoing percutaneous coronary intervention comprises aspirin with a potent P2Y …
undergoing percutaneous coronary intervention comprises aspirin with a potent P2Y …
Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point–Blinded, Noninferiority …
H Wu, L Xu, X Zhao, H Zhang, K Cheng, X Wang… - Circulation, 2023 - Am Heart Assoc
Background: Dual antiplatelet therapy (DAPT) with aspirin as a background therapy has
become the standard care after percutaneous coronary intervention. However, some …
become the standard care after percutaneous coronary intervention. However, some …
Durable polymer versus biodegradable polymer drug-eluting stents after percutaneous coronary intervention in patients with acute coronary syndrome: the HOST …
Background: Large-scale randomized comparison of drug-eluting stents (DES) based on
durable polymer versus biodegradable polymer technology is currently insufficient in …
durable polymer versus biodegradable polymer technology is currently insufficient in …
[HTML][HTML] Platelet function and genotype after DES implantation in East Asian patients: rationale and characteristics of the PTRG-DES consortium
Purpose Platelet function test (PFT) results and genotype hold unique prognostic
implications in East Asian patients. The aim of the PTRG-DES (Platelet function and …
implications in East Asian patients. The aim of the PTRG-DES (Platelet function and …